Purpose. The uncertainty in supply and the short shelf life of blood products have led to a substantial outdating of the collected donor blood. On the other hand, hospitals and blood centers experience severe blood shortage due to the very limited donor population. Therefore, the necessity to forecast the blood supply to minimize outdating as well as shortage is obvious. This study aims to efficiently forecast the supply of blood components at blood centers. Methods. Two different types of forecasting techniques, time series and machine learning algorithms, are developed and the best performing method for the given case study is determined. Under the time series, we consider the Autoregressive (AUTOREG), Autoregressive Moving Average (ARMA), Autoregressive Integrated Moving Average (ARIMA), Seasonal ARIMA, Seasonal Exponential Smoothing Method (ESM), and Holt-Winters models. Artificial neural network (ANN) and multiple regression are considered under the machine learning algorithms. Results. We leverage five years worth of historical blood supply data from the Taiwan Blood Services Foundation (TBSF) to conduct our study. On comparing the different techniques, we found that time series forecasting methods yield better results than machine learning algorithms. More specifically, the least value of the error measures is observed in seasonal ESM and ARIMA models. Conclusions. The models developed can act as a decision support system to administrators and pathologists at blood banks, blood donation centers, and hospitals to determine their inventory policy based on the estimated future blood supply. The forecasting models developed in this study can help healthcare managers to manage blood inventory control more efficiently, thus reducing blood shortage and blood wastage.
Purpose. Blood, like fresh produce, is a perishable element, with platelets having a limited lifetime of five days and red blood cells lasting 42 days. To manage the blood supply chain more effectively under demand and supply uncertainty, it is of considerable importance to developing a practical blood supply chain model. This paper proposed an essential blood supply chain model under demand and supply uncertainty. Methods. This study focused on how to manage the blood supply chain under demand and supply uncertainty effectively. A stochastic mixed-integer linear programming (MILP) model for the blood supply chain is proposed. Furthermore, this study conducted a sensitivity analysis to examine the impacts of the coefficient of demand and supply variation and the cost parameters on the average total cost and the performance measures (units of shortage, outdated units, inventory holding units, and purchased units) for both the blood center and hospitals. Results. Based on the results, the hospitals and the blood center can choose the optimal ordering policy that works best for them. From the results, we observed that when the coefficient of demand and supply variation is increased, the expected supply chain cost increased with more outdating units, shortages units, and holding units due to the impacts of supply and demand fluctuation. Variation in the inventory holding and expiration costs has an insignificant effect on the total cost. Conclusions. The model developed in this paper can assist managers and pathologists at the blood donation centers and hospitals to determine the most efficient inventory policy with a minimum cost based on the uncertainty of blood supply and demand. The model also performs as a decision support system to help health care professionals manage and control blood inventory more effectively under blood supply and demand uncertainty, thus reducing shortage of blood and expired wastage of blood.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.